We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
-4.93%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$98.8B
AUM Growth
-$3.4B
Cap. Flow
+$2.69B
Cap. Flow %
2.72%
Top 10 Hldgs %
24.29%
Holding
4,219
New
200
Increased
1,781
Reduced
1,776
Closed
283
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SBLK icon
2676
Star Bulk Carriers
SBLK
$3.11B
$650K ﹤0.01%
37,209
-17,163
-32% -$391K
SCHE icon
2677
Schwab Emerging Markets Equity ETF
SCHE
$12.9B
$650K ﹤0.01%
29,014
+160
+0.6% +$3.95K
NWBI icon
2678
Northwest Bancshares
NWBI
$2.31B
$649K ﹤0.01%
48,035
+1,087
+2% +$15.1K
SH icon
2679
ProShares Short S&P500
SH
$839M
$648K ﹤0.01%
9,381
+435
+5% +$27.3K
XHE icon
2680
State Street SPDR S&P Health Care Equipment ETF
XHE
$169M
$648K ﹤0.01%
7,596
+837
+12% +$77.6K
EMBC icon
2681
Embecta
EMBC
$290M
$647K ﹤0.01%
22,464
-5,983
-21% -$177K
TNET icon
2682
TriNet
TNET
$3.07B
$647K ﹤0.01%
9,078
+450
+5% +$36.6K
QCRH icon
2683
QCR Holdings
QCRH
$1.73B
$646K ﹤0.01%
12,675
-800
-6% -$44.7K
VFVA icon
2684
Vanguard US Value Factor ETF
VFVA
$945M
$645K ﹤0.01%
7,433
-220
-3% -$21.3K
SLI
2685
Standard Lithium
SLI
$574M
$644K ﹤0.01%
148,690
+89,009
+149% +$466K
PJP icon
2686
Invesco Pharmaceuticals ETF
PJP
$497M
$641K ﹤0.01%
8,997
-39
-0.4% -$2.91K
IBMP icon
2687
iShares iBonds Dec 2027 Term Muni Bond ETF
IBMP
$658M
$640K ﹤0.01%
26,226
+1,015
+4% +$25.6K
FEZ icon
2688
State Street SPDR EURO STOXX 50 ETF
FEZ
$4.56B
$639K ﹤0.01%
20,763
-1,341
-6% -$46.2K
BSMM
2689
DELISTED
Invesco BulletShares 2022 Municipal Bond ETF
BSMM
$639K ﹤0.01%
25,272
-2,549
-9% -$64.5K
XMVM icon
2690
Invesco S&P MidCap Value with Momentum ETF
XMVM
$511M
$638K ﹤0.01%
16,497
+1,234
+8% +$51.9K
CAKE icon
2691
Cheesecake Factory
CAKE
$5.57B
$636K ﹤0.01%
+21,725
New +$659K
NWSA icon
2692
News Corp Class A
NWSA
$15.5B
$635K ﹤0.01%
42,043
+11,867
+39% +$199K
TEN
2693
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
$635K ﹤0.01%
36,500
+954
+3% +$17.9K
NAVI icon
2694
Navient
NAVI
$867M
$632K ﹤0.01%
+43,005
New +$656K
QVCGA
2695
DELISTED
QVC Group Inc Series A
QVCGA
$631K ﹤0.01%
6,279
+94
+2% +$13.6K
RIGS icon
2696
ALPS Strategic Income Fund
RIGS
$60.6M
$629K ﹤0.01%
28,304
-2,660
-9% -$60.9K
FTCI icon
2697
FTC Solar
FTCI
$40.1M
$628K ﹤0.01%
21,217
+692
+3% +$28.9K
SXI icon
2698
Standex International
SXI
$4B
$626K ﹤0.01%
7,669
+609
+9% +$54.4K
TNC icon
2699
Tennant Co
TNC
$1.15B
$626K ﹤0.01%
11,060
+94
+0.9% +$5.89K
BGFV
2700
DELISTED
Big 5 Sporting Goods
BGFV
$625K ﹤0.01%
58,230
-1,220
-2% -$14.8K

Similar funds

Raymond James & Associates's Q3 2022 Portfolio in Review

As of Q3 2022, Raymond James & Associates held 4,219 positions worth $98.8B, down 3.3% from $102B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Raymond James & Associates's Q3 2022 filing shows 200 new, 1,781 increased, 1,776 reduced and 283 closed positions. Its largest new stake was JPMorgan Nasdaq Equity Premium Income ETF: 332,653 shares worth $13.9M. The largest sale was iShares Core 1-5 Year USD Bond ETF, an estimated $255M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 13% a quarter earlier, followed by Healthcare and Financials.

  • Raymond James & Associates's largest Q3 2022 buy was JPMorgan Nasdaq Equity Premium Income ETF: 332,653 shares worth $13.9M.
  • Raymond James & Associates added most to iShares Core US Aggregate Bond ETF in Q3 2022, an estimated $620M increase.
  • Raymond James & Associates's biggest Q3 2022 reduction was iShares Core 1-5 Year USD Bond ETF, cutting an estimated $255M.
  • Raymond James & Associates fully exited CDK Global, Inc. in Q3 2022, selling an estimated $36M.
  • Raymond James & Associates's ten largest holdings make up 24% of its $98.8B portfolio in Q3 2022.
  • Raymond James & Associates opened 200 new positions and closed 283 in Q3 2022.
  • Raymond James & Associates's portfolio value fell 3.3% quarter-over-quarter to $98.8B.

Based on Raymond James & Associates's 13F filing for Q3 2022, filed 25 Oct 2022.